T. Rowe Price Associates
ADPT

T. Rowe Price Associates’s Adeptus Health Inc ADPT Stock Holding History

T. Rowe Price Associates’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,114,797
Closed -$48M – 2580
2016
Q3 		$48M Sell
1,114,797
-399,781
-26% -$18M 0.01% 819
2016
Q2 		$78.2M Sell
1,514,578
-767,097
-34% -$46M 0.02% 645
2016
Q1 		$127M Sell
2,281,675
-59,903
-3% -$3.1M 0.03% 490
2015
Q4 		$128M Buy
2,341,578
+50,390
+2% +$3.21M 0.03% 499
2015
Q3 		$185M Buy
2,291,188
+1,115,418
+95% +$115M 0.04% 424
2015
Q2 		$112M Buy
1,175,770
+364,400
+45% +$25.1M 0.02% 573
2015
Q1 		$40.7M Buy
811,370
+3,890
+0.5% +$154K 0.01% 903
2014
Q4 		$30.2M Sell
807,480
-81,800
-9% -$2.58M 0.01% 1011
2014
Q3 		$22.1M Buy
+889,280
New +$23.2M ﹤0.01% 1082

Other funds holding ADPT

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Axon Capital New York $73.7M AUM
SFM
Sterling Fund Management Chicago, Illinois $1.82M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

T. Rowe Price Associates's ADPT Position: Q4 2016 in Review

T. Rowe Price Associates sold out of Adeptus Health Inc (ADPT) in Q4 2016, closing a stake of 1,114,797 shares — an estimated $48M sold.

T. Rowe Price Associates first reported a position in ADPT in Q3 2014 and held it in 9 quarters. The position peaked at $185M in Q3 2015. 106 funds tracked by Wall St. Rank hold ADPT as of Q4 2016.

  • T. Rowe Price Associates reported no remaining Adeptus Health Inc position as of Q4 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,114,797 Adeptus Health Inc shares in Q4 2016, an estimated $48M.
  • T. Rowe Price Associates first reported a position in Adeptus Health Inc in Q3 2014 and held it in 9 quarters.
  • T. Rowe Price Associates's Adeptus Health Inc position peaked at $185M in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q4 2016.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.